Abiopharma

LINDIAN verwerft resterend belang van 49 % en verkrijgt 100 % eigendom van de operationele hydrometallurgische faciliteit van SARECO

Q2/half-yearly Periodic report for 2026

Report of Periodic or Interim Report

General Announcement: Net Asset Value ("NAV") as of 07 August 2026

Issuance to employees

TGS Vesting Under the 2023 Long-term Incentive Plan

Private offering

Invitation to an annual meeting for 16.9.26 – voting form and more

Management and officers – staffing as of 10.8.26

Immidiate Report